Heartflow, Inc. (NASDAQ:HTFL) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Heartflow, Inc. (NASDAQ:HTFL) have been assigned an average recommendation of “Moderate Buy” from the twelve analysts that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation, eight have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $44.8750.

Several equities analysts have weighed in on HTFL shares. Morgan Stanley raised their target price on Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a report on Friday, August 14th. Benchmark reiterated a “buy” rating on shares of Heartflow in a research note on Friday, August 14th. Robert W. Baird set a $45.00 price objective on Heartflow in a research note on Friday, August 14th. Stifel Nicolaus boosted their target price on Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a report on Friday, August 14th. Finally, Canaccord Genuity Group upped their target price on Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a research report on Friday, August 14th.

Insider Transactions at Heartflow

In related news, CEO John Farquhar sold 27,230 shares of Heartflow stock in a transaction on Friday, August 21st. The shares were sold at an average price of $50.00, for a total value of $1,361,500.00. Following the transaction, the chief executive officer owned 360,814 shares in the company, valued at $18,040,700. This trade represents a 7.02% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 9,219 shares of the business’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $41.23, for a total transaction of $380,099.37. Following the transaction, the insider directly owned 86,459 shares of the company’s stock, valued at approximately $3,564,704.57. This represents a 9.64% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 208,765 shares of company stock worth $8,444,106. 7.70% of the stock is owned by insiders.

Hedge Funds Weigh In On Heartflow

A number of institutional investors have recently made changes to their positions in the business. XXEC Inc. bought a new stake in Heartflow during the 2nd quarter valued at approximately $2,524,764,000. BlackRock Inc. bought a new position in Heartflow in the 2nd quarter worth approximately $152,502,000. Wellington Management Group LLP bought a new position in Heartflow in the 3rd quarter worth approximately $164,263,000. Bamco Inc. NY acquired a new position in shares of Heartflow during the second quarter worth approximately $94,625,000. Finally, Jupiter Topco LLC bought a new stake in shares of Heartflow in the second quarter valued at approximately $70,983,000.

Heartflow Stock Up 9.7%

Shares of HTFL opened at $49.88 on Friday. The firm has a market cap of $4.34 billion and a price-to-earnings ratio of -27.26. The company’s fifty day moving average is $35.52 and its 200-day moving average is $30.78. Heartflow has a 12 month low of $20.13 and a 12 month high of $51.78.

Heartflow (NASDAQ:HTFL) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.15. The business had revenue of $64.08 million during the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The firm’s revenue was up 47.7% on a year-over-year basis. As a group, research analysts predict that Heartflow will post -0.75 earnings per share for the current fiscal year.

About Heartflow

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.

The company’s primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).